Sanofi Sues FDA, Claiming Agency Exceeded Its Authority In Approving Enoxaparin
Company claims the agency approved the generic although the innovator drug had not been fully characterized, but odds are against a Sanofi win in court.
Company claims the agency approved the generic although the innovator drug had not been fully characterized, but odds are against a Sanofi win in court.